Osteosarcopenia: The Modern Geriatric Giant

https://doi.org/10.1016/B978-0-12-801238-3.11421-7Get rights and content

Abstract

Osteoporosis, the most common bone disease in humans, shares distinct pathophysiological mechanisms with sarcopenia. Sarcopenia, characterized by low muscle strength, mass and physical performance, is an important disease in older adults. Where osteoporosis/osteopenia and sarcopenia are present, this is termed ‘osteosarcopenia.’ A contemporary, comprehensive geriatric assessment should include assessment for osteosarcopenia and its associated risks, as this will enable effective management to reduce adverse outcomes. This chapter introduces the concept of osteosarcopenia as a geriatric syndrome, including its pathophysiology and assessment, and outlines current treatment options. We also describe the frontiers of research in the important and burgeoning arena of osteosarcopenia.

References (0)

Cited by (2)

  • A clinical guide to the pathophysiology, diagnosis and treatment of osteosarcopenia

    2020, Maturitas
    Citation Excerpt :

    Other diagnostic tools such as peripheral DXA (pDXA), quantitative computed tomography (QCT), quantitative ultrasound (QUS), and radiographic absorptiometry can also be used to assess BMD and fracture risk. Given that an absolute majority of fractures in older adults occur in persons with BMD in the normal or osteopenic range, these techniques all have high specificity but low sensitivity for fracture prediction [47]. Except for whole-body magnetic resonance imaging (MRI), which is not feasible in practice, all currently available techniques to assess muscle are approximations.

  • Osteosarcopenia

    2021, Sarcopenia: Second Edition
View full text